CellSource Co., Ltd. (4880) Stock Analysis | Price, Returns, Financials & Key Metrics

Mojo Score Change: CellSource Co., Ltd. has changed its score on 05 Dec 2025. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

The company has declared Negative results for the last 6 consecutive quarters

NET SALES(HY) At JPY 1,820.5 MM has Grown at -18.28%
NET PROFIT(HY) At JPY 4.82 MM has Grown at -98.38%
ROCE(HY) Lowest at -0.84%

Risky -

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 11,848 Million (Micro Cap)

P/E

357.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.74

Return on Equity

-1.06%

Price to Book

1.99

Revenue and Profits:

Net Sales:

971 Million

(Quarterly Results - Apr 2025)

Net Profit:

57 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-21.41%

6 Months

-31.09%

1 Year

-53.03%

2 Years

-66.17%

3 Years

-90.2%

4 Years

-93.61%

5 Years

-84.3%

CellSource Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

18.65%

EBIT Growth (5y)

-173.68%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.72

Sales to Capital Employed (avg)

0.84

Tax Ratio

58.23%

Dividend Payout Ratio

41.61%

Pledged Shares

Institutional Holding

ROCE (avg)

115.51%

ROE (avg)

16.13%

Valuation key factors

Factor

Value

P/E Ratio

357

Industry P/E

Price to Book Value

2.28

EV to EBIT

-66.17

EV to EBITDA

304.89

EV to Capital Employed

5.64

EV to Sales

2.28

PEG Ratio

Dividend Yield

ROCE (Latest)

-8.52%

ROE (Latest)

0.64%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 14.38% vs -16.23% in Jan 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 224.40% vs 66.62% in Jan 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "971.30",
          "val2": "849.20",
          "chgp": "14.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "125.40",
          "val2": "-9.50",
          "chgp": "1,420.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.80",
          "val2": "4.40",
          "chgp": "-36.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "56.60",
          "val2": "-45.50",
          "chgp": "224.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "81.60%",
          "val2": "-73.20%",
          "chgp": "15.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Oct'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Oct 2024 is -3.45% vs 5.54% in Oct 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Oct 2024 is -74.23% vs -9.30% in Oct 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Oct'24",
        "Oct'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,355.10",
          "val2": "4,510.50",
          "chgp": "-3.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "282.40",
          "val2": "1,287.90",
          "chgp": "-78.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "0.40",
          "chgp": "250.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "10.20",
          "val2": "-16.20",
          "chgp": "162.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "237.90",
          "val2": "923.10",
          "chgp": "-74.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.70%",
          "val2": "270.80%",
          "chgp": "-24.11%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ

Apr'25

Jan'25

Change(%)

Net Sales

971.30

849.20

14.38%

Operating Profit (PBDIT) excl Other Income

125.40

-9.50

1,420.00%

Interest

0.30

Exceptional Items

2.80

4.40

-36.36%

Consolidate Net Profit

56.60

-45.50

224.40%

Operating Profit Margin (Excl OI)

81.60%

-73.20%

15.48%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Apr 2025 is 14.38% vs -16.23% in Jan 2025

Consolidated Net Profit

QoQ Growth in quarter ended Apr 2025 is 224.40% vs 66.62% in Jan 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Oct'24

Oct'24

Oct'23

Change(%)

Net Sales

4,355.10

4,510.50

-3.45%

Operating Profit (PBDIT) excl Other Income

282.40

1,287.90

-78.07%

Interest

1.40

0.40

250.00%

Exceptional Items

10.20

-16.20

162.96%

Consolidate Net Profit

237.90

923.10

-74.23%

Operating Profit Margin (Excl OI)

29.70%

270.80%

-24.11%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Oct 2024 is -3.45% vs 5.54% in Oct 2023

Consolidated Net Profit

YoY Growth in year ended Oct 2024 is -74.23% vs -9.30% in Oct 2023

All Annual Results

Company CV

About CellSource Co., Ltd.

CellSource Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available